The expression levels of FBXW7 in most malignancies are downregulated compared to normal tissues, such as glioma, lung cancer, liver cancer, urothelial cancer, ovarian cancer, and melanoma (18), which have a positive correlation with prognosis of patients, aside from liver cancer and melanoma. Here, FBXW7 is linked to central nervous system cancer.